The IFIK is home to the Swiss National Reference Centre for Pneumococci and to the Swiss National Centre for Antibiotic Resistance (anresis.ch) mandated by the Federal Office of Public Health. These activities are complemented by strategic and investigator-driven research projects in academic research laboratories working in the fields of antimicrobial resistance, central nervous system infection, diagnostic innovation, microbial genomics and host-microbiota interaction, and mucosal infections.
IFIK is home to basic and clinical research groups (view links below for detailed information). Currently, more than 60 researchers with backgrounds in medicine and biological sciences work in the IFIK research department. The 3 main research focuses are antimicrobial resistance development, infections of the central nervous system (CNS), and airway and gut mucosal microbial health and infection.
Over the past 30 years, we have seen a dramatic increase in bacteria resistant to commonly used antibiotics. The Endimiani group focus on the molecular characterization of these pathogens, linking it to the clinical outcome of infected patients. Moreover, the group contributes to development novel therapeutic approaches and new techniques to speed up the diagnosis of serious infections.